# Integer Holdings Corporation (ITGR) Stock Analysis: A 29.83% Upside Potential in the Medical Devices Sector

- Link: https://www.directorstalkinterviews.com/integer-holdings-corporation-itgr-stock-analysis-a-29-83-upside-potential-in-the-medical-devices-sector/4121209668
- Published: 2025-07-28T10:46:41+01:00
- Author: Madison Wilson

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare 
sector specializing in medical devices, presents a compelling case for investors
with its robust growth potential and strong analyst endorsements. With a market 
capitalization of $3.8 billion, Integer operates on a global scale, serving a broad
spectrum of the healthcare market, including interventional cardiology and neuromodulation.

Currently trading at $108.51, ITGR has experienced a modest price change of 0.01%,
positioning itself towards the lower end of its 52-week trading range of $106.73
to $144.36. This pricing provides an attractive entry point for investors considering
the company’s substantial upside potential. Analyst ratings are notably bullish,
with nine buy recommendations and only one hold, reflecting strong confidence in
the company’s future performance.

One of the standout metrics for Integer is its projected potential upside of 29.83%,
calculated from the average analyst target price of $140.88. The target range spans
from $132.00 to $155.00, indicating a consensus view that the stock is currently
undervalued. This optimism is supported by the company’s solid revenue growth of
11.40%, which underscores its ability to expand in a competitive industry.

While Integer’s trailing P/E ratio is not available, its forward P/E ratio of 15.23
suggests a relatively attractive valuation in comparison to industry peers. The 
company’s return on equity stands at 5.15%, a respectable figure that highlights
efficient use of shareholder capital amid its expansive operations. The free cash
flow of $114.38 million further reinforces Integer’s strong financial positioning,
providing flexibility for strategic investments and potential debt reduction.

Despite lacking a dividend yield, Integer’s commitment to reinvesting earnings into
growth opportunities is evident. The absence of a payout ratio aligns with its focus
on enhancing shareholder value through capital appreciation rather than dividend
distribution.

From a technical perspective, the stock’s current price is below both its 50-day
moving average of $118.80 and its 200-day moving average of $126.91. This technical
setup may signal a potential rebound, especially with an RSI of 52.45, which indicates
a neutral momentum. The MACD and signal line, both in negative territory, suggest
that investors should remain vigilant for shifts in momentum that could herald a
price recovery.

Operating in high-demand markets like cardiac rhythm management and portable medical
devices, Integer is strategically positioned to capitalize on growing healthcare
needs. The company’s comprehensive product offerings, from implantable devices to
advanced surgical tools, make it an essential partner for leading OEMs globally.

Founded in 1970 and headquartered in Plano, Texas, Integer Holdings Corporation 
has evolved significantly, rebranding from Greatbatch, Inc. in 2016 to align more
closely with its innovative and expansive vision. This strategic evolution highlights
its commitment to addressing complex medical challenges, a mission that continues
to drive its growth and appeal to investors seeking exposure to the resilient healthcare
sector.

For investors looking to tap into the medical devices industry with a focus on innovation
and global reach, Integer Holdings Corporation offers a promising opportunity. With
strong growth metrics, analyst confidence, and a considerable upside potential, 
ITGR stands out as a noteworthy consideration for portfolios targeting long-term
growth in the healthcare space.

Share on:
